Skip to main content

Table 3 Comparison between the need for THA surgery after core decompression with investigated variables

From: Evaluation of core decompression outcome in systemic lupus erythematosus with hip osteonecrosis: a retrospective cohort study

With/without THA

Uni-variable logistic regression

Multivariable logistic regression

Odds ratio (CI 95%)

P value

Odds ratio (CI 95%)

P value

Male gender

0.48 (0.028–8.348)

0.614

  

Bilateral Hip osteonecrosis

3.600 (0.385–33.637)

0.261

Abnormal C3, C4 levels

4.714 (1.026–21.651)

0.046*

0.649 (0.075–5.579)

0.694

Abnormal aPL levels

4.714 (1.026–21.651)

0.046*

3.068 (0.488–19.290)

0.232

SLE relapse

9.048 (1.912–42.808)

0.005**

1.795 (0.166–19.439)

0.630

Kidney damage

2.625 (0.642–10.728)

0.179

  

Neuro damage

0.458 (0.046–4.578)

0.506

Azathioprine

14.929 (2.625–84.890)

0.002**

HCQ

1.000 (0.206–4.856)

1.000

Methotrexate

1.867 (0.405–8.614)

0.424

Mycophenolate mofetil

0.764 (0.127–4.596)

0.768

Aspirin

0.278 (0.067–1.147)

0.077

0.391 (0.063–2.409)

0.311

Statins

1.000 (0.206–4.856)

1.000

  

Bisphosphonate

0.606 (0.148–2.486)

0.487

Smoking (Cigarette)

1.260 (0.250–6.350)

0.779

Alcohol

0.350 (0.036–3.358)

0.363

Anti-ds DNA level

With independent sample T test

93.23–102.52 (IU/ml)

0.66

  
  1. SLE: systemic lupus erythmatosus, HCQ: hydroxychloroquine, aPL: antiphospholipid antibodies